Changing the paradigm in heart failure: shifting from treatment to prevention

Martin SS, Aday AW, Almarzooq ZI et al (2024) 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 149(8):e347–e913. https://doi.org/10.1161/CIR.0000000000001209

Article  PubMed  Google Scholar 

Bleumink GS, Knetsch AM, Sturkenboom MC et al (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25(18):1614–1619. https://doi.org/10.1016/j.ehj.2004.06.038

Article  PubMed  Google Scholar 

Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22(4 Suppl A):6A-13A. https://doi.org/10.1016/0735-1097(93)90455-a

Article  CAS  PubMed  Google Scholar 

Nichols GA, Qiao Q, Déruaz-Luyet A, Kraus BJ (2023) The clinical burden of newly diagnosed Heart failure among patients with Reduced, mildly Reduced, and preserved ejection fraction. Int J Cardiol Heart Vasc 47:101182. Published 2023 Feb 14. https://doi.org/10.1016/0735-1097(93)90455-a

Steinberg BA, Zhao X, Heidenreich PA et al (2012) Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 126(1):65–75. https://doi.org/10.1161/CIRCULATIONAHA.111.080770

Article  PubMed  Google Scholar 

Tsao CW, Lyass A, Enserro D et al (2018) temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail 6(8):678–685. https://doi.org/10.1016/j.jchf.2018.03.006

Article  PubMed  PubMed Central  Google Scholar 

Dunlay SM, Weston SA, Jacobsen SJ, Roger VL (2009) Risk factors for heart failure: a population-based case-control study. Am J Med 122(11):1023–1028. https://doi.org/10.1016/j.amjmed.2009.04.022

Article  PubMed  PubMed Central  Google Scholar 

Sinha A, Ning H, Carnethon MR et al (2021) Race- and sex-specific population attributable fractions of incident heart failure: a population-based cohort study from the lifetime risk pooling project. Circ Heart Fail 14(4):e008113. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008113

Article  PubMed  PubMed Central  Google Scholar 

Ho JE, Enserro D, Brouwers FP et al (2016) Predicting heart failure with preserved and reduced ejection fraction: the international collaboration on heart failure subtypes. Circ Heart Fail 9(6):e003116. https://doi.org/10.1161/CIRCHEARTFAILURE.115.003116

Article  PubMed  Google Scholar 

Fliotsos M, Zhao D, Rao VN et al (2018) Body mass index from early-, Mid-, and older-adulthood and risk of heart failure and atherosclerotic cardiovascular disease: MESA. J Am Heart Assoc 7(22):e009599. https://doi.org/10.1161/JAHA.118.009599

Article  PubMed  PubMed Central  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 145(18):e895–e1032. https://doi.org/10.1161/CIR.0000000000001063

Article  PubMed  Google Scholar 

Bassi NS, Ziaeian B, Yancy CW, Fonarow GC (2020) Association of optimal implementation of sodium-glucose cotransporter 2 inhibitor therapy with outcome for patients with heart failure. JAMA Cardiol 5(8):948–951. https://doi.org/10.1001/jamacardio.2020.0898

Article  PubMed  Google Scholar 

Bozkurt B, Ahmad T, Alexander KM, et al (2013) Heart failure epidemiology and outcomes statistics: a report of the heart failure society of America. J Card Fail 29(10):1412–1451. https://doi.org/10.1016/j.cardfail.2023.07.006Huffman

Huffman MD, Berry JD, Ning H et al (2013) Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project. J Am Coll Cardiol 61(14):1510–1517. https://doi.org/10.1016/j.jacc.2013.01.022

Article  PubMed  PubMed Central  Google Scholar 

Kenchaiah S, Evans JC, Levy D et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313. https://doi.org/10.1056/NEJMoa020245

Article  PubMed  Google Scholar 

Schocken DD, Benjamin EJ, Fonarow GC et al (2008) Prevention of heart failure: a scientific statement from the American Heart Association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 117(19):2544–2565. https://doi.org/10.1161/CIRCULATIONAHA.107.188965

Article  PubMed  Google Scholar 

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [published correction appears in N Engl J Med. 2008;18(4):4]. N Engl J Med 351(13):1296–1305. https://doi.org/10.1056/NEJMoa041031

Khan SS, Matsushita K, Sang Y, et al (2024) Development and Validation of the American Heart Association 's PREVENT Equations [published correction appears in Circulation. 2024 Mar 12;149(11):e956]. Circulation 149(6):430–449. https://doi.org/10.1161/CIRCULATIONAHA.123.067626

Khan SS, Coresh J, Pencina MJ et al (2023) Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-Kidney-Metabolic Health: a scientific statement from the American Heart Association. Circulation 148(24):1982–2004. https://doi.org/10.1161/CIR.0000000000001191

Article  PubMed  Google Scholar 

US Census Quick Facts. Available at: https://www.census.gov/quickfacts/fact/table/US/PST045217. Accessed 22 Ap 2024

Rodriguez F, Chung S, Blum MR, Coulet A, Basu S, Palaniappan LP (2019) Atherosclerotic cardiovascular disease risk prediction in disaggregated Asian and hispanic subgroups using electronic health records. J Am Heart Assoc 8(14):e011874. https://doi.org/10.1161/JAHA.118.011874

Article  PubMed  PubMed Central  Google Scholar 

Arnett DK, Blumenthal RS, Albert MA et al (2019) 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task force on clinical practice guidelines. Circulation 140(11):e596–e646. https://doi.org/10.1161/CIR.0000000000000678

Article  PubMed  PubMed Central  Google Scholar 

Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA (2016) Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 354:i4482. Published 2016 Sep 6. https://doi.org/10.1136/bmj.i4482

Kirchhof P, Camm AJ, Goette A et al (2020) Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 383(14):1305–1316. https://doi.org/10.1056/NEJMoa2019422

Article  PubMed  Google Scholar 

Kenchaiah S, Narula J, Vasan RS (2004) Risk factors for heart failure. Med Clin North Am 88(5):1145–1172. https://doi.org/10.1016/j.mcna.2004.04.016

Article  PubMed  Google Scholar 

Adler ED, Voors AA, Klein L, et al (2020) Improving risk prediction in heart failure using machine learning [published correction appears in Eur J Heart Fail. 2020 Dec;22(12):2399. https://doi.org/10.1002/ejhf.2072]. Eur J Heart Fail 22(1):139–147. https://doi.org/10.1002/ejhf.1628

Ledwidge M, Gallagher J, Conlon C et al (2013) Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA 310(1):66–74. https://doi.org/10.1001/jama.2013.7588

Article  CAS  PubMed  Google Scholar 

Lakhani I, Wong MV, Hung JKF et al (2021) Diagnostic and prognostic value of serum C-reactive protein in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart Fail Rev 26(5):1141–1150. https://doi.org/10.1007/s10741-020-09927-x

Article  CAS  PubMed  Google Scholar 

Cleland JGF, Ferreira JP, Mariottoni B et al (2021) The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart “OMics” in AGEing (HOMAGE) randomized clinical trial. Eur Heart J 42(6):684–696. https://doi.org/10.1093/eurheartj/ehaa758

Article  CAS  PubMed  Google Scholar 

Levitan EB, Wolk A, Mittleman MA (2009) Consistency with the DASH diet and incidence of heart failure. Arch Intern Med 169(9):851–857. https://doi.org/10.1001/archinternmed.2009.56

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levitan EB, Wolk A, Mittleman MA (2009) Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. Am J Cardiol 104(10):1416–1420. https://doi.org/10.1016/j.amjcard.2009.06.061

Article  PubMed  PubMed Central  Google Scholar 

Tektonidis TG, Åkesson A, Gigante B, Wolk A, Larsson SC (2016) Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men. Eur J Heart Fail 18(3):253–259. https://doi.org/10.1002/ejhf.481

Article  PubMed  Google Scholar 

Lara KM, Levitan EB, Gutierrez OM, et al (2019) Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease. J Am Coll Cardiol 73(16):2036–2045. https://doi.org/10.1016/j.jacc.2019.01.067

Young DR, Reynolds K, Sidell M et al (2014) Effects of physical activity and sedentary time on the risk of heart failure. Circ Heart Fail 7(1):21–27. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000529

Article  PubMed 

Comments (0)

No login
gif